Loading clinical trials...
Loading clinical trials...
A Phase 2 Clinical Trial Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of PRAX-944 in Adults With Essential Tremor
Conditions
Interventions
Part A: 20 and 40 mg PRAX-944
Part B: 120 mg PRAX-944
+1 more
Locations
9
United States
Praxis Research Site
Port Charlotte, Florida, United States
Praxis Research Site
Spokane, Washington, United States
Praxis Research Site
New Lambton Heights, New South Whales, Australia
Praxis Research Site
Southport, Queensland, Australia
Praxis Research Site
Fitzroy, Victoria, Australia
Praxis Research Site
Melbourne, Victoria, Australia
Start Date
March 3, 2020
Primary Completion Date
March 24, 2022
Completion Date
March 24, 2022
Last Updated
March 1, 2024
NCT07428447
NCT07417280
NCT04212780
NCT03984643
NCT01581580
NCT07056361
Lead Sponsor
Praxis Precision Medicines
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions